The Brugada syndrome: Facts and controversies

Herz

Volumn 32, Issue 3, 2007, Pages 192-200

  Boussy, Tim ^b   Sarkozy, Andrea ^b   Chierchia, Gian Battista ^b   Richter, Sergio ^b   Brugada, Pedro ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b NONE

Author keywords

Brugada syndrome; Sudden cardiac death

Indexed keywords

AJMALINE; DIHYDROQUINIDINE; DIMETHYL LITHOSPERMATE B; FLECAINIDE; PILSICAINIDE; PROCAINAMIDE; QUINIDINE; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG;

BRUGADA SYNDROME; DEFIBRILLATION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; NONHUMAN; PROGNOSIS; REVIEW; SUDDEN DEATH; SYNCOPE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUSCLE PROTEINS; RISK ASSESSMENT; SODIUM CHANNELS;

EID: 34250173060     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-2979-y     Document Type: Review

References (45)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
2. Tohyou Y, Nakazawa K, Ozawa A, et al. A survey in the incidence or right bundle branch block with ST-segment elevation among normal population. Jpn J Electrocardiol 1995;15:223-6.
3. Hata Y, Chiba N, Hotta K, et al. Incidence and clinical significance of right bundle branch block and ST-segment elevation in V1-V3 in 6- to 18-year old schoolchildren in Japan. Circulation 1997;20:2310.
4. Miyasaka Y, Tsuji H, Yamada K, et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001;38:771-4.
5. Greer RW, Glancy DL. Prevalence of the Brugada electrocardiographic pattern at the Medical Center of Louisiana in New Orleans. J La State Med Soc 2003;155:242-6.
6. Hermida JS, Lemoine JL, Aoun FB, et al. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86:91-4.
7. Vatta M, Dumaine R, Varghese G, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002;11:337-45.
8. Bordachar P, Reuter S, Garrigue S, et al. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 2004;25:879-84.
9. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Circulation 2005;111:659-70.
10. Sarkozy A, Boussy T, Kourgiannides G, et al. Long-term follow-up of primary prophylactic implantable cardioverterdefibrillator therapy in Brugada syndrome. Eur Heart J 2007;28:334-44.
11. Richter S, Sarkozy A, Chierchia GB, et al. Variability of the diagnostic coved-type ECG during long-term follow-up of patients with Brugada syndrome and primary prophylactic ICD implantation. Eur Heart J 2006,27:Suppl 1:AB88662.
12. Veltmann C, Schimpf R, Echternach C, et al. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006;27:2544-52.
13. Hong K, Brugada J, Oliva A, et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004;110:3023-7.
14. Meregalli PG, Ruijter JM, Hofman N, et al. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome J Cardiovasc Electrophysiol 2006;17:857-64.
15. Wolpert C, Echternach C, Veltmann C, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005;2:254-60.
16. Ikeda T, Abe A, Yusu S, et al. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol 2006;17:602-7.
17. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
18. Weiss R, Barmada MM, Nguyen T, et al. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 2002;105:707-13.
19. Probst V, Allouis M, Sacher F, et al. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 2006;17:270-5.
20. Bezzina CR, Shimizu W, Yang P, et al. Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation 2006:113:338-44.
21. Poelzing S, Forleo C, Samodell M, et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 2006;114:368-76.
22. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999;100:1660-6.
23. Meregallli PG, Wilde AAM, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005;67:367-78.
24. Frustaci A, Priori SG, Pieroni M, et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005;112:3680-7.
25. Coronel R, Casini S, Koopmann T, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome. Circulation 2005;112:2769-77.
26. Kataoka H. Electrocardiographic patterns of the Brugada syndrome in right ventricular infarction/ischemia. Am J Cardiol 2000;86:1056.
27. Araki T, Konno T, Itoh H, et al. Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia. Circ J 2003;67:93-5.
28. Antzelevitch C, Brugada R. Fever and Brugada syndrome. PACE 2002;25:1537-9.
29. Osborn JJ. Experimental hypothermia; respiratory and blood pH changes in relation to cardiac function. Am J Physiol 1953;175:389-98.
30. Noda T, Shimizu W, Tanaka K, et al. Prominent J-wave and ST-segment elevation: serial electrocardiographic changes in accidental hypothermia. J Cardiovasc Electrophysiol 2003;14:223.
31. Nogami A, Nakao M, Kubota S, et al. Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome. PACE 2003;26:332-7.
32. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-5.
33. Goldgran-Toledano D, Sideris G, Kevorkian JP. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 2002;346:1591-2.
34. Tada H, Sticherling C, Oral H, et al. Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 2001;12:275.
35. Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. J Electrocardiol 2001;34:345-9.
36. Controversies in cardiovascular medicine: should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Part I: Brugada P, Brugada R, Brugada J. Patients with an asymptomatic Brugada electrocardiogram should undergo pharmacological and electrophysiological testing. Part II: Priori SG, Napolitano C. Management of patients with Brugada syndrome should not be based on programmed electrical stimulation. Circulation 2005;112:279-92.
37. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-7.
38. Brugada J, Brugada R, Antzelevitch C. et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
39. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-6.
40. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-63.
41. Sacher F, Probst V, Iesaka Y, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. Circulation 2006;114:2317-24.
42. Brugada P, Brugada J, Brugada R. The fortuitous individual with a Brugada-like electrocardiogram. Heart Rhythm 2005;AB31-2.
43. Fish JM, Welchons DR, Kim Y, et al. Dimethyl lithospermate B, an extract of Danshen suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 2006;113:1393-400.
44. Hermida JS, Denjoy I, Clerc J, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004;43:1853-60.
45. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high risk patients with Brugada syndrome. Circulation 2004;110:1731-7.